Alteration in urease-producing bacteria in the gut microbiomes of patients with inflammatory bowel diseases.

Journal of Crohn's & Colitis
Ron RyvchinUri Gophna

Abstract

Bacterial urease is a major virulence factor of human pathogens, and murine models have shown that it can contribute to the pathogenesis of inflammatory bowel diseases [IBD]. The distribution of urease-producing bacteria in IBD was assessed using public fecal metagenomic data from various cohorts, including non-IBD controls (n = 55), patients with Crohn's disease (n = 291), ulcerative colitis (n = 214), and patients with a pouch (n = 53). The ureA gene, and the taxonomic markers gyrA, rpoB and recA were used to estimate the percentage of urease producers in each sample. Levels of urease producers in patients with IBD and non-IBD controls were comparable. In non-IBD controls and most IBD patients, urease-producers were primarily acetate producing genera such as Blautia and Ruminococcus. A shift in the type of the dominant urease producers towards Proteobacteria and Bacilli was observed in a subset of all IBD subtypes, which correlated with fecal calprotectin levels in one cohort. Some patients with IBD had no detectable urease producers.In patients with a pouch the probiotic-associated species Streptococcus thermophilus was more common as a main urease producer than in other IBD phenotypes, and it generally did not co-occur with...Continue Reading

References

Mar 1, 1979·Applied and Environmental Microbiology·K SuzukiJ Hase
Mar 1, 1990·Gut·M V MaddenR J Nicholls
Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Mar 8, 1980·Lancet·R F Harvey, J M Bradshaw
Sep 1, 1995·Microbiological Reviews·H L MobleyR P Hausinger
May 1, 1994·Gut·J G Ruseler-van EmbdenL M van Lieshout
Oct 15, 1998·Gut·R S WalmsleyR N Allan
Jul 8, 2003·The British Journal of Nutrition·Peter FaberGerald E Lobley
Sep 11, 2003·Microbiology and Molecular Biology Reviews : MMBR·Paul D Cotter, Colin Hill
Sep 6, 2005·Research in Microbiology·Nathalie MaroncleChristiane Forestier
Jun 16, 2006·Inflammatory Bowel Diseases·Michael R Konikoff, Lee A Denson
Jan 26, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Severine VermeirePaul Rutgeerts
Jan 26, 2010·Biochemical and Biophysical Research Communications·Virginia AiassaInés Albesa
Sep 22, 2011·Inflammatory Bowel Diseases·Nabeetha A Nagalingam, Susan V Lynch
Dec 30, 2011·Journal of Clinical Microbiology·Claudia M BarberisCarlos A Vay
Jun 20, 2013·Nature Immunology·Nobuhiko KamadaGabriel Núñez
Oct 10, 2013·Journal of Microbiological Methods·Tugba Onal Okyay, Debora Frigi Rodrigues
Mar 19, 2014·Cell Host & Microbe·Dirk GeversRamnik J Xavier
Apr 4, 2014·Bioinformatics·Anthony M BolgerBjoern Usadel
May 17, 2014·PLoS Pathogens·Julian C Rutherford
Jun 21, 2014·Immunity·Curtis HuttenhowerRamnik J Xavier
Dec 17, 2014·PLoS Pathogens·Diego Mora, Stefania Arioli
May 15, 2015·Cell Host & Microbe·Marta WlodarskaRamnik J Xavier
Jun 24, 2015·Proceedings of the National Academy of Sciences of the United States of America·Kathryn E HoltNicholas R Thomson
Sep 30, 2015·Nature Methods·Duy Tin TruongNicola Segata
Nov 17, 2017·Science Translational Medicine·Josephine NiGary D Wu
Apr 12, 2019·Nature Microbiology·Eric A FranzosaRamnik J Xavier
Sep 7, 2019·Journal of Oral Microbiology·Yaohua YangJirong Long
Oct 31, 2020·Nucleic Acids Research·Jaina MistryAlex Bateman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.